TR201700265A2 - THERAPEUTIC USE OF ADIPOKINETIC HORMONE / RED PIGMENT-CONCENTRATING HORMONE (AKH / RPCH) PEPTITES FAMILY - Google Patents
THERAPEUTIC USE OF ADIPOKINETIC HORMONE / RED PIGMENT-CONCENTRATING HORMONE (AKH / RPCH) PEPTITES FAMILY Download PDFInfo
- Publication number
- TR201700265A2 TR201700265A2 TR2017/00265A TR201700265A TR201700265A2 TR 201700265 A2 TR201700265 A2 TR 201700265A2 TR 2017/00265 A TR2017/00265 A TR 2017/00265A TR 201700265 A TR201700265 A TR 201700265A TR 201700265 A2 TR201700265 A2 TR 201700265A2
- Authority
- TR
- Turkey
- Prior art keywords
- hormone
- rpch
- akh
- red pigment
- family
- Prior art date
Links
- 101800002326 Adipokinetic hormone Proteins 0.000 title abstract 6
- 101800001365 Red pigment-concentrating hormone Proteins 0.000 title abstract 6
- XFGMPZRFMGBTDI-UHFFFAOYSA-N p-Glu-Leu-Asn-Phe-Ser-Pro-Gly-Trp-NH2 Natural products C=1C=CC=CC=1CC(C(=O)NC(CO)C(=O)N1C(CCC1)C(=O)NCC(=O)NC(CC=1C2=CC=CC=C2NC=1)C(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C1CCC(=O)N1 XFGMPZRFMGBTDI-UHFFFAOYSA-N 0.000 title abstract 6
- XFGMPZRFMGBTDI-POFDKVPJSA-N (2s)-n-[(2s)-1-[[(2s)-1-[(2s)-2-[[2-[[(2s)-1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2s)-4-methyl-2-[[(2s)-5-oxopyrrolidine-2-carbonyl]amino]pe Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(N)=O)C(=O)[C@@H]1CCC(=O)N1 XFGMPZRFMGBTDI-POFDKVPJSA-N 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 206010000217 Abortion incomplete Diseases 0.000 abstract 1
- 206010000234 Abortion spontaneous Diseases 0.000 abstract 1
- 208000006630 Incomplete Abortion Diseases 0.000 abstract 1
- 206010000210 abortion Diseases 0.000 abstract 1
- 231100000176 abortion Toxicity 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000008602 contraction Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000003754 fetus Anatomy 0.000 abstract 1
- 208000015994 miscarriage Diseases 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 208000000995 spontaneous abortion Diseases 0.000 abstract 1
- 210000004291 uterus Anatomy 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Mevcut buluş Adipokinetik hormon/Kırmızı pigment-konsantre edici hormon (AKH/RPCH) peptit ailesinin üyesi olan peptitlerin yeni bir kullanımı ile ilgilidir. Buluş özellikle uterusta kasılma oluşturmaya yönelik bir ajan olarak Adipokinetik hormon/Kırmızı pigment-konsantre edici hormon (AKH/RPCH) peptit ailesi ile ilgili olup; tamamlanmamış kürtaj veya düşük durumunda fetusun aborsiyonuna yardım etmek, zor doğum sırasında kasılma oluşturmak, doğumdan sonra kanamayı kontrol etmek ve doğum hasarına bağlı oluşan hastalıklara karşı koruma sağlamak için sunulması ile ilgilidir.The present invention relates to a novel use of peptides which are members of the peptide family of adipokinetic hormone / red pigment-concentrating hormone (AKH / RPCH). In particular, the invention relates to the Adipokinetic hormone / Red pigment-concentrating hormone (AKH / RPCH) peptide family as an agent for contracting the uterus; in the case of incomplete abortion or miscarriage, to assist the abortion of the fetus, to create contractions during difficult labor, to control bleeding after birth and to protect against diseases caused by birth damage.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/00265A TR201700265A2 (en) | 2017-01-09 | 2017-01-09 | THERAPEUTIC USE OF ADIPOKINETIC HORMONE / RED PIGMENT-CONCENTRATING HORMONE (AKH / RPCH) PEPTITES FAMILY |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/00265A TR201700265A2 (en) | 2017-01-09 | 2017-01-09 | THERAPEUTIC USE OF ADIPOKINETIC HORMONE / RED PIGMENT-CONCENTRATING HORMONE (AKH / RPCH) PEPTITES FAMILY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201700265A2 true TR201700265A2 (en) | 2018-11-21 |
Family
ID=67069728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/00265A TR201700265A2 (en) | 2017-01-09 | 2017-01-09 | THERAPEUTIC USE OF ADIPOKINETIC HORMONE / RED PIGMENT-CONCENTRATING HORMONE (AKH / RPCH) PEPTITES FAMILY |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR201700265A2 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12139556B2 (en) | 2022-10-25 | 2024-11-12 | Solasta Bio Limited | Insect neuropeptides 6 |
| US12245596B1 (en) | 2023-10-23 | 2025-03-11 | Solasta Bio Limited | Insect neuropeptides 8 |
| US12245588B1 (en) | 2023-10-23 | 2025-03-11 | Solasta Bio Limited | Insect neuropeptides 2 |
| US12279621B1 (en) | 2023-10-23 | 2025-04-22 | Solasta Bio Limited | Insect neuropeptides 3 |
| US12281143B1 (en) | 2023-10-23 | 2025-04-22 | Solasta Bio Limited | Insect neuropeptides 1 |
| US12302908B2 (en) | 2023-10-23 | 2025-05-20 | Solasta Bio Limited | Insect neuropeptides 4 |
| US12356995B2 (en) | 2023-10-23 | 2025-07-15 | Solasta Bio Limited | Insect neuropeptides 9 |
-
2017
- 2017-01-09 TR TR2017/00265A patent/TR201700265A2/en unknown
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12139556B2 (en) | 2022-10-25 | 2024-11-12 | Solasta Bio Limited | Insect neuropeptides 6 |
| US12404302B2 (en) | 2022-10-25 | 2025-09-02 | Solasta Bio Limited | Insect neuropeptides 6 |
| US12245596B1 (en) | 2023-10-23 | 2025-03-11 | Solasta Bio Limited | Insect neuropeptides 8 |
| US12245588B1 (en) | 2023-10-23 | 2025-03-11 | Solasta Bio Limited | Insect neuropeptides 2 |
| US12279621B1 (en) | 2023-10-23 | 2025-04-22 | Solasta Bio Limited | Insect neuropeptides 3 |
| US12281143B1 (en) | 2023-10-23 | 2025-04-22 | Solasta Bio Limited | Insect neuropeptides 1 |
| US12302908B2 (en) | 2023-10-23 | 2025-05-20 | Solasta Bio Limited | Insect neuropeptides 4 |
| US12356995B2 (en) | 2023-10-23 | 2025-07-15 | Solasta Bio Limited | Insect neuropeptides 9 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Galliano et al. | MicroRNA and implantation | |
| MA45599A (en) | NEUROACTIVE STEROIDS SUBSTITUTED FOR C17, C20 AND C21 AND THEIR USE PROCEDURES | |
| EA201791361A1 (en) | THERAPY ANTAGONIST OF OXYTOCIN RECEPTORS INTO LUTE PHASE FOR IMPLANTATION AND PREGNANCY IN WOMEN THROUGH PROCEDURES OF AUXILIARY REPRODUCTIVE TECHNOLOGIES | |
| EA201791675A1 (en) | HUMAN ANTIBODIES TO GLOBOPROTEIN OF EBOL VIRUS | |
| BR112015029953A2 (en) | anti-tweakr antibodies and their uses | |
| MX2017008186A (en) | Human antibodies to influenza hemagglutinin. | |
| CR20190095A (en) | NEW T-LYMPHOCYTE AND IMMONOTHERAPY RECEPTORS BASED ON THE USE OF THE SAME | |
| WO2019002444A9 (en) | Novel t cell receptors and immune therapy using the same | |
| MX2017003268A (en) | ANTIBODIES OF A SINGLE DOMAIN DIRECTED AGAINST INTRACELLULAR ANTIGENS | |
| MX2016011537A (en) | Methods and compositions for increasing a t-effector cell to regulatory t cell ratio. | |
| JO3537B1 (en) | Enhanced amyloid beta-peptide AB primary fibrillary antibodies | |
| BR112016022055A2 (en) | alpha tnf binding elements | |
| EP3908656A4 (en) | GAS VESIKE EXPRESSION SYSTEMS, GAS VESIKE CONSTRUCTS AND RELATED GENETIC REGULATIONS, VECTORS, MAMMALIAN CELLS, HOSTS, COMPOSITIONS, PROCESSES AND SYSTEMS | |
| PH12017501865A1 (en) | Antibody-mediated neutralization of chikungunya virus | |
| CY1122615T1 (en) | THERAPY WITH STEM CELLS IN ENDOMETRIUM DISEASES | |
| BR112012032182A2 (en) | high affinity human antibodies to human cytomegalovirus (cmv) gb protein. | |
| AR107067A1 (en) | FORMULATIONS AND METHODS TO CONTROL THE REPRODUCTIVE CYCLE AND OVULATION | |
| BR112014024751A2 (en) | clostridium difficile antigens | |
| CL2017003201A1 (en) | Variants of il-37 | |
| NZ602380A (en) | Peptides for vaccine against birch allergy | |
| EA201791525A3 (en) | CONNECTIONS FOR THE TREATMENT OF THE BLOCADE OF REMIELINIZATION IN DISEASES RELATED TO THE EXPRESSION OF THE PROTECTIVE PROTEIN | |
| EA201990106A1 (en) | RECEPTION MODE OF A SELECTIVE PROGESTERON RECEPTOR MODULATOR (SPRM) | |
| Mei et al. | Defects in NKG2D ligand expression result in failed tolerance induction at the maternal–fetal interface: A possible cause for recurrent miscarriage | |
| WO2015173430A3 (en) | Early placenta insulin-like peptide (pro-epil) | |
| UY37651A (en) | IL-1R-I UNION POLYPEPTIDE |